FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula and their pharmaceutically acceptable salts and esters. The disclosed compounds have cdk4 inhibition properties. In formula (I) n equals 0 or 1; R1 and R2 are each independently selected from a group consisting of H, lower alkyl, CO2R5, SO2R6 and COR6; or alternatively, R1 and R2 can form a ring containing 5-6 atoms in the ring, where the said ring contains carbon atoms, where the said carbon atoms are optionally substituted with oxygen, and the said atoms in the ring are optionally substituted with OR6; R3 is selected from a group consisting of H, lower alkyl, O-lower alkyl, halogen, OH, CN, NO2 and COOH; R4 is selected from a group consisting of H, lower alkyl, C3-C6-cycloalkyl, O-lower alkyl, halogen, NO2, S-lower alkyl, NR5R6, CONR7R8, OH and CN; or alternatively R3 and R4, together with two carbon atoms and the bond between them from the benzene ring, to which R3 and R4 are bonded, can form a ring containing 5-7 atoms, where the said 5-7-member ring contains carbon atoms, where the said carbon atoms are optionally substituted with one or two heteroatoms selected from O and N, and the said atoms in the ring are optionally substituted with CO2R6; R4 represents H or halogen; R5 and R6 are each independently selected from a group consisting of H and lower alkyl; R7 and R8 each represents H. The invention also relates to a pharmaceutical composition for treating or controlling diseases progression of which can be enhanced by inhibiting cdk4, containing an effective amount of the disclosed compound as an active ingredient, to use of disclosed compounds for preparing medicinal agents and method of producing said compounds.
EFFECT: more effective treatment.
30 cl, 1 tbl, 142 ex
Title | Year | Author | Number |
---|---|---|---|
DIAMINOTHIAZOLES POSSESSING PROPERTY OF CYCLIN-DEPENDENT KINASE 4 INHIBITOR | 2003 |
|
RU2311414C2 |
CIS-2,4,5-TRIPHENYLIMIDAZOLINES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2305095C2 |
NOVEL 2,4-DIAMINOTHIAZOL-5-ONE DERIVATIVES | 2005 |
|
RU2395501C2 |
SPIROINDOLINONE PYRROLIDINES, USEFUL WHEN TREATING MALIGNANT GROWTHS | 2010 |
|
RU2571100C2 |
CIS-IMIDAZOLINES AS MDM2 INHIBITORS | 2004 |
|
RU2354649C2 |
SOME SUBSTITUTED AMIDES, METHOD OF THEIR OBTAINING AND METHOD OF THEIR APPLICATION | 2006 |
|
RU2418788C2 |
DIARYLAMINE-CONTAINING COMPOUNDS, COMPOSITIONS AND USE THEREOF AS c-KIT RECEPTOR MODULATORS | 2006 |
|
RU2436776C2 |
1-(2-AMINOBENZOL)PIPERAZINE DERIVATIVES AS GLYCIN UPTAKE INHIBITORS TO BE USED FOR PSYCHOSIS TREATMENT | 2004 |
|
RU2354653C2 |
2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
PYRAZOLEPYRIMIDINES | 2005 |
|
RU2412186C2 |
Authors
Dates
2010-02-27—Published
2005-04-08—Filed